The SECURE-SCD Registry has reported that as of May 15, 2020, 172 persons with sickle cell have been reported as having caught the Coronavirus. 14 fatalities have been recorded.
SCD Type: SS (71.35%), SC (19.88%), SBeta zero Thal (4.68%). Sbeta Thal (4.09%) of the total affected.
Age: The average age of those affected is 29.75 with a standard deviation of 13.75.
Sex: More females (56.98%) than males (41.86%) have been affected
Presenting Symptoms: Symptoms SCD patients affected by the Coronavirus presented with include Pain(62.21%), and Pneumonia (30.81%), Some presented with a combination of Pain and Pnuemonia. Other less significant symptoms include kidney failure, splenic sequestration, pulmonary hypertension, arrythmias, aplastic crises and stroke.
Treatment: Sickle cell patients with the Coronavirus were treated with
- BLOOD TRANSFUSION
- INTENSIVE CARE
Ethnicity: Black/African Americans are by far the most affected. Whites, Asians, southern Europeans, Hispanics and others occupy just a tiny fraction of the affected population.
Countries Affected: Brazil, USA, Canada, Greece, Swizerland, Oman (Middle East)
Fatalities: 14 SCD patients affected with COVID-19 have died.
No known infections or fatalities recorded so far, a ‘miracle’ for a continent ill-prepared for such medical emergencies.